Discussion meeting on Phase-Contrast Breast CT

Tuesday 5 Sept 2017, 14:00 → 19:10 Europe/Rome

Seminar Room, T1 building, I floor (Elettra, Trieste)

Giuliana Tromba (Elettra Sincrotrone Trieste), Renata Longo (TS)

Exchanging experience towards a clinical study with SR

14:00 → 14:05 Welcome

a short introduction

Speakers: Dr Giuliana Tromba, Renata Longo (TS)

14:05 → 14:35 A visual grading analysis of propagation-based phase-contrast CT mammography

Speaker: Dr Patrick Brennan

Slides Radiological_assessment_of_propagation-based_phase-contrast_CT_mammograp.pdf

14:35 → 14:55 The contribution of breast CT to breast diagnosis

(remote access)

Speaker: Dr Susanne Wienbeck

14:55 → 15:10 Objective evaluation of Image quality in propagation-based phase-contrast breast CT

Speaker: Ms Serena Pacile

Slides Objective_evaluation.pdf

15:10 → 15:40 On the “unreasonable” effectiveness of Homogeneous Transport of Intensity imaging

Speaker: Dr Tim Gureyev

Slides Elettra_5Sep17_Gureyev4.pdf

15:40 → 16:00 coffe break

16:00 → 16:20 SYRMA-CT /3D project: the INFN & ELETTRA collaboration for the clinical study

Speaker: Renata Longo (TS)

Slides SYRMA_3D_Longo.pdf

16:20 → 16:35 Characteristics of breast CT protocol at SYRMEP

Speaker: Dr Giuliana Tromba

Slides GT_sept5_fin.pdf

16:35 → 16:50 Dose evaluation

Speaker: Giovanni Mettivier (NA)

Slides Syrma3D-Dosimetry.pdf

16:50 → 17:05 PIXIRAD detector: characteristics and imaging results

Speakers: Pasquale Delogu (PI), Vittorio Di Trapani

Slides PIXIRAD_INFN.pdf

17:05 → 17:25 tea break

17:25 → 19:05 Discussion

Important topics in view of the clinical trial at SYRMEP

Short contributions are welcome.
- Optimization of imaging protocol (choice of energy, num. of projections, distance, dose limits, etc)
- Optimization of pre-processing and reconstruction workflow (ring and artifact removal, reconstruction algorithm, phase- retrieval parameters)
- Image quality evaluation & modalities for radiological assessment
- Radiological study: recruitment criteria, aim of the trial, dose limits, etc.

Conveners: Dr Giuliana Tromba, Renata Longo (TS)